1. Home
  2. GPCR vs NSSC Comparison

GPCR vs NSSC Comparison

Compare GPCR & NSSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • NSSC
  • Stock Information
  • Founded
  • GPCR 2016
  • NSSC 1969
  • Country
  • GPCR United States
  • NSSC United States
  • Employees
  • GPCR N/A
  • NSSC N/A
  • Industry
  • GPCR
  • NSSC Telecommunications Equipment
  • Sector
  • GPCR
  • NSSC Telecommunications
  • Exchange
  • GPCR Nasdaq
  • NSSC Nasdaq
  • Market Cap
  • GPCR 1.8B
  • NSSC 1.5B
  • IPO Year
  • GPCR 2023
  • NSSC N/A
  • Fundamental
  • Price
  • GPCR $34.17
  • NSSC $35.96
  • Analyst Decision
  • GPCR Buy
  • NSSC Strong Buy
  • Analyst Count
  • GPCR 5
  • NSSC 6
  • Target Price
  • GPCR $86.80
  • NSSC $47.00
  • AVG Volume (30 Days)
  • GPCR 677.5K
  • NSSC 505.2K
  • Earning Date
  • GPCR 11-13-2024
  • NSSC 11-04-2024
  • Dividend Yield
  • GPCR N/A
  • NSSC 1.39%
  • EPS Growth
  • GPCR N/A
  • NSSC 46.22
  • EPS
  • GPCR N/A
  • NSSC 1.36
  • Revenue
  • GPCR N/A
  • NSSC $191,147,000.00
  • Revenue This Year
  • GPCR N/A
  • NSSC $9.69
  • Revenue Next Year
  • GPCR N/A
  • NSSC $13.02
  • P/E Ratio
  • GPCR N/A
  • NSSC $26.44
  • Revenue Growth
  • GPCR N/A
  • NSSC 11.02
  • 52 Week Low
  • GPCR $26.61
  • NSSC $27.86
  • 52 Week High
  • GPCR $66.38
  • NSSC $58.09
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 35.81
  • NSSC 37.31
  • Support Level
  • GPCR $33.85
  • NSSC $31.77
  • Resistance Level
  • GPCR $38.48
  • NSSC $39.66
  • Average True Range (ATR)
  • GPCR 2.62
  • NSSC 1.46
  • MACD
  • GPCR -0.36
  • NSSC -0.08
  • Stochastic Oscillator
  • GPCR 3.67
  • NSSC 52.64

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, a validated G-protein-coupled receptors (GPCRs) drug target for type-2 diabetes mellitus and obesity. The company is also developing oral small-molecule therapeutics targeting other GPCRs for the treatment of pulmonary and cardiovascular diseases, including ANPA-0073 and LTSE-2578.

About NSSC NAPCO Security Technologies Inc.

NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses.

Share on Social Networks: